These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35581512)
1. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment. Jiang J; Sheng C; Chen G; Liu C; Jin S; Li L; Jiang X; Han Y; Geroscience; 2022 Aug; 44(4):2319-2336. PubMed ID: 35581512 [TBL] [Abstract][Full Text] [Related]
2. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052 [TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820 [TBL] [Abstract][Full Text] [Related]
4. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion. Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523 [TBL] [Abstract][Full Text] [Related]
5. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI. Ben Bouallègue F; Mariano-Goulart D; Payoux P; J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345 [TBL] [Abstract][Full Text] [Related]
6. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415 [TBL] [Abstract][Full Text] [Related]
7. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. Strom A; Iaccarino L; Edwards L; Lesman-Segev OH; Soleimani-Meigooni DN; Pham J; Baker SL; Landau SM; Jagust WJ; Miller BL; Rosen HJ; Gorno-Tempini ML; Rabinovici GD; La Joie R; Brain; 2022 Apr; 145(2):713-728. PubMed ID: 34373896 [TBL] [Abstract][Full Text] [Related]
8. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve. Yoshizawa H; Gazes Y; Stern Y; Miyata Y; Uchiyama S Psychiatry Res; 2014 Jan; 221(1):78-85. PubMed ID: 24262800 [TBL] [Abstract][Full Text] [Related]
9. Association between Benton Visual Retention Test Scores and PET Imaging in Elderly Adults. Abe M; Kimura N; Sasaki Y; Eguchi A; Matsubara E Curr Alzheimer Res; 2021; 18(11):900-907. PubMed ID: 34875990 [TBL] [Abstract][Full Text] [Related]
10. Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data. Sörensen A; Blazhenets G; Rücker G; Schiller F; Meyer PT; Frings L; Neuroimage Clin; 2019; 21():101637. PubMed ID: 30553760 [TBL] [Abstract][Full Text] [Related]
11. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD). Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111 [TBL] [Abstract][Full Text] [Related]
12. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease. Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938 [TBL] [Abstract][Full Text] [Related]
13. Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment. Apostolova I; Lange C; Suppa P; Spies L; Klutmann S; Adam G; Grothe MJ; Buchert R; Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1417-1422. PubMed ID: 29502311 [TBL] [Abstract][Full Text] [Related]
14. Deep learning based diagnosis of Alzheimer's disease using FDG-PET images. Kishore N; Goel N Neurosci Lett; 2023 Nov; 817():137530. PubMed ID: 37858874 [TBL] [Abstract][Full Text] [Related]
15. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19. Ferrucci R; Cuffaro L; Capozza A; Rosci C; Maiorana N; Groppo E; Reitano MR; Poletti B; Ticozzi N; Tagliabue L; Silani V; Priori A J Neurol; 2023 Apr; 270(4):1823-1834. PubMed ID: 36692636 [TBL] [Abstract][Full Text] [Related]
16. Glucose hypometabolism in the Auditory Pathway in Age Related Hearing Loss in the ADNI cohort. Zainul Abidin FN; Scelsi MA; Dawson SJ; Altmann A; Neuroimage Clin; 2021; 32():102823. PubMed ID: 34624637 [TBL] [Abstract][Full Text] [Related]
17. Distinct subtypes of spatial brain metabolism patterns in Alzheimer's disease identified by deep learning-based FDG PET clusters. Ryoo HG; Choi H; Shi K; Rominger A; Lee DY; Lee DS; Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):443-454. PubMed ID: 37735259 [TBL] [Abstract][Full Text] [Related]
18. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers. Ota K; Oishi N; Ito K; Fukuyama H; ; J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727 [TBL] [Abstract][Full Text] [Related]
19. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077 [TBL] [Abstract][Full Text] [Related]